2 курс / Гистология / Востриков_В_М_Олигодендроглия_в_мозге_человека_при_шизофрении
.pdf181
Автореферат диссертации на соискание ученой степени доктора
медицинских наук. М., 1995.
49.Щербакова И.В., Каледа В.Г., Бархатова А.Н., Клюшник Т.П. Маркеры эндотелиальной дисфункции при приступообразной шизофрении. // Журн. невропатологии и психиатрии им. С.С. Корсакова, 2005, 105: 43-46.
50.Aberg К., Saetre P., Lindholm Е., Ekholm В., Pettersson U., Adolfsson R., Jazin E. Human QKI, a new candidate gene for schizophrenia involved in myelination. // Am. J. Medical Genetics. B: Neuropsychiatric Genetics, 2006, 141: 84-90.
51.Adler СМ., Adams J., DelBello M.P., Holland S.K., Schmithorst V., Levine A., Jarvis K., Strakowski S.M. Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study. // Am. J. Psychiatry, 2006, 163: 2, 322-324.
52.Adler СМ., Holland S.K., Schmithorst V., Wilke M., Weiss K.L, Pan H., Strakowski S.M. Abnormal frontal white matter tracts in bipolar disorder: a diffusion tensor imaging study. // Bipolar Disord., 2004, 6: 3, 197-203.
53.Alexopoulos G.S., Kiosses D.N., Choi S.J., Murphy Ch.F., Lim K.O. Frontal white matter microstructure and treatment response of late-life depression: A preliminary study. // Am. J. Psychiatry, 2002, 159: 19291932.
54.Alonso G. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. // Glia, 2000, 31:3, 219-231.
55.Ambrosi G., Virgintino D., Benagiano V., Maiorano E., Bertossi M., Roncali L. Glial cells and blood-brain barrier in the human cerebral cortex. //Ital. J. Anat. Embryol., 1995, 100 Suppl 1: 177-184.
56.Andreasen N.C., Olsen S. Negative versus positive schizophrenia: definition and validation. // Arch. Gen. Psychiatry, 1982, 39: 789-794.
182
57.Andreasen N.C. The evolving concept of schizophrenia: from Kraepelin to the present and future. // Schizophr. Res., 1997, 28: 105-109.
58.Angelucci F., Brene S., Mathe A.A. BDNF in schizophrenia, depression and corresponding animal models. // Mol. Psychiatry, 2005, 10: 4, 345-352.
59.Arnold S.E., Trojanowski J.Q., Gur R.E., Blackwell P., Han L.-Y., Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of erderly patients with schizophtenia. // Arch. Gen. Psychiatry, 1998, 55: 225-232.
60.Arvindakshan M., Sitasawad S., Debsikdar V., Ghate M., Evans D., Horrobin D.F., Bennett C, Ranjekar P.K., Mahadik S.P. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. // Biol. Psychiatry, 2003, 53: 56-64.
61.Asher R.A., Morgenstern D.A., Shearer M.C., Adcock K.H., Pesheva P., Fawcett J.W. Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. // J. Neurosci., 2002, 22: 2225-2236.
62.Aston C, Jiang L., Sokolov B.P. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. // J. Neuroscience Research, 2004, 77: 858-866.
63.Aston C, Jiang L., Sokolov B.P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. // Mol. Psychiatry, 2005, 10: 309-322.
64.Bahn S., Jones P.B. Gene expression in schizophrenia and bipolar disorder. // Schizophr. Res., 2003, 60: 60.
65.Bal-Klara A. Effects of some antidepressant drugs on the activity of glial cell enzymes in culture. // European J. Pharmacology, 1989, 161: 231235.
183
66.Bartzokis G. Brain mielination in prevalent neuropsichiatric developmental disorders: primary and comorbid addiction. Adolesc. Psychyc, 2005, 29: 55-96.
67.Bartzokis G., Nuechterlein K.H., Lu P.H., Gitlin M., Rogers S., Mintz J. Dysregulated brain development in adult men with schizophrenia: A magnetic resonance imaging study. // Biol. Psychiatry, 2003, 53: 412-
68.Baslow M.H., Hrabe J., Guilfoyle D.N. Dynamic relationship between neurostimulation and N-acetylaspartate metabolism in the human visual cortex: evidence that NAA functions as a molecular water pump during visual stimulation. // J. Mol. Neurosci., 2007, 32: 3, 235-245.
69.Baslow M.H., Guilfoyle D.N. Effect of N-acetylaspartic acid on the diffusion coefficient of water: a proton magnetic resonance phantom method for measurement of osmolyte-obligated water. // Anal Biochem., 2002,311:2,133-138.
70.Baud O., Greene A.E., Li J., Wang H., Volpe J.J., Rosenberg P.A. Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. // J. Neurosci., 2004,
24:1531-1540.
71.Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small intemeurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. // Arch.Gen.Psychiatry, 1991, 48:996-1001.
72.Benes F.M., Vincent S.L., Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. // Biol Psychiatry, 2001, 50: 6, 395-406.
73.Benes F.M., Davidson J., Bird E.D. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. // Arch. Gen. Psychiatry, 1986,43:31-35.
184
74.Berger G.E., Smesny S., Amminger G.P. Bioactive lipids in schizophrenia. // Int. Rev. Psychiatry, 2006, 18: 85-98.
75.Bernardo A., Greco A., Levi G., Minghetti L. Differential lipid peroxidation, Mn superoxide, and bcl-2 expression contribute to the maturation-dependent vulnerability of oligodendrocytes to oxidative stress.
//J. Neuropathol., Exp. Neurol., 2003, 62: 509-519.
76.Bertolino A., Esposito G., Callicott J.H., Mattay V.S., Van Horn J.D., Frank J.A., Berman K.F., Weinberger D.R. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. // Am. J. Psychiatry, 2000, 157:26-33.
77.Bertolino A., Sciota D., Brudaglio F., Altamura M., Blasi G., Bellomo A., Antonucci N., Callicott J.H., Goldberg Т.Е., Scarabino Т., Weinberger D.R., Nardini M. Working memory deficits and levels of N- acetylaspartate in patients with schizophreniform disorder. // Am. J. Psychiatry, 2003, 160: 483^89.
78.Bertram I., Bernstein H.G., Lendeckel U., Bukowska A., Dobrowolny H., Keilhoff G., Kanakis D., Marwin C, Bielau H., Falkai P., Bogerts B. Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression. //Ann. NY Acad. Sci., 2007, 1096: 147-156.
79.Beyer J.L. and Krishnan K.R. Volumetric brain imaging findings in mood disorders. // Bipolar Disord., 2002, 4: 89-104.
80.Beyer J.L., Taylor W.D., MacFall J.R., Kuchibhatla M., Payne M.E., Provenzale J.M., Cassidy F., Krishnan K.R. Cortical white matter microstructural abnormalities in bipolar disorder. // Neuropsychopharmacology, 2005, 30: 12, 2225-2229.
81.Bieber A.J., Warrington A., Pease L.R., Rodriguez M. Humoral autoimmunity as a mediator of CNS repair. // Trends Neurosci., 2001, 24: (11 Suppl), S39-44.
185
82.Black J.E., Kodish I.M., Grossman A.W., Klintsova A.Y., Orlovskaya D.D., Vostrikov V.M, Uranova N.A., Greenough W.T. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. //Am. J. Psychiatry, 2004, 161: 4, 742-744.
83.Brakebusch C, Seidenbecher CI, Asztely F, Rauch U, Matthies H, Meyer H, Krug M, Bockers TM, Zhou X, Kreutz MR, Montag D, Gundelfinger ED, Fassler R. Brevican-deficient mice display impaired hippocampal CA1 long-term potentiation but show no obvious deficits in learning and memory. Mol Cell Biol. 2002, 22: 21, 7417-7427.
84.Brambilla P., Barale F., Caverzasi E., Soares J.C. Anatomical MRI findings in mood and anxiety disorders. // Epidemiol. Psichiatr. Soc, 2002, 11:2,88-99.
85.Broadbelt K., Byne W., Jones L.B. Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. // Schizophr. Res., 2002, 58: 1, 75-81.
86.Buchsbaum M.S., Freidman J., Buchsbaum B.R., Chu K.W., Hazlet E.A., Newmark R., Schneiderman J.S., Torosjan Y., Tang Ch., Hof P.R., Stewart D., Davis K.L., Gorman J. Diffusion tensor imaging in schizophrenia. // Biol. Psychiatry, 2006, 60: 1181-1187.
87.Buchsbaum M.S., Schoenknecht P., Torosjan Y., Newmark R., Chu K-W., Mitelman S., AdamMBrickman A.M., Shihabuddin L., Haznedar M.M., Hazlett E.A., Shabeer Ahmed S., Tang Ch. Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. // Ann. of Gen. Psychiatry, 2006, 5:19, doi:10.1186/1744-859X-5-19
88.Buckley P.F., Pillai A., Evans D., Stirewalt E., Mahadik S. Brain derived neurotropic factor in first-episode psychosis. // Schizophr Res., 2007,91: 1-3,1-5.
89.Buckley P.F. Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implication. // Neuropsychiatr. Dis. Treat, 2005,1: 193-204.
186
90.Bunge R.P. Glial cells and the central myelin sheath. // Physiol. Rev., 1968,48: 197-251.
91.Burbaeva G.Sh., Boksha I.S., Tereshkina E.B., Savushkina O.K., Starodubtseva L.I., Turishcheva M.S., Elizabeta Mukaetova-Ladinska E. Systemic neurochemical alterations in schizophrenic brain: glutamate metabolism in focus. //Neurochem. Res., 2007, 32: 9, 1434-1444.
92.Burbaeva G.Sh., Boksha I.S., Turishcheva M.S., Vorobyeva E.A., Savushkina O.K., Tereshkina E.B. Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia. // Prog. Neuropsychopharmacol. Biol. Psychiatry, 2003, 27: 4, 675-680.
93.Burdo J.R., Martin J., Menzies S.L., Dolan K.G., Romano M.A., Fletcher R.J., Garrick M.D., Garrick L.M., Connor J.R. Cellular distribution of iron in the brain of the Belgrade rat. // Neuroscience, 1999, 93:3,1189-1196.
94.Butovsky O., Landa G., Kunis G., Ziv Y., Avidan H., Greenberg N., Schwartz A., Smirnov I., Pollack A., Jung S., Schwartz M. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. // J. Clin. Invest., 2006, 116: 4, 905-
95.Byne W., Kidkardnee S., Tatusov A., Yiannoulos G., Buchsbaum M.S., Haroutuian V. Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. // Schizophr. Res., 2006, 85: 245-253.
96.Byravan S., Foster L.M., Phan Т., Verity A.N., Campagnoni A.T. Murine oligodendroglial cells express nerve growth factor. // Proc. Natl. Acad. Sci. USA, 1994, 91: 8812-8816.
97.Callicott J.H., Bertolino A., Egan M.F., Mattay V.S., Langheim F.J., Weinberger D.R. Selective relationship between prefrontal N- acetylaspartate measures and negative symptoms in schizophrenia. // Am. J. Psychiatry, 2000, 157: 1646-1651.
187
98.Cannela В., Pitt D., Marchionni M., Raine C.S. Neuroregulin and erbB receptor expression in normal and diseased human white matter. // J. Neuroimmunol., 1999, 100: 233-242.
99.Carulli D., Rhodes K.E., Fawcett J.W. Upregulation of aggrecan, link protein 1, and hyaluronan synthases during formation of perineuronal nets in the rat cerebellum. // J. Сотр. Neurol., 2007, 501: 1, 83-94.
100.Casanova M.F., Stevens J.R., Kleinman J.E. Astrocytosis in the molecular layer of the dentate gyrus: a study in Alzheimer's disease and schizophrenia.//Psychiatry Res., 1990,35: 149-166.
101.Castro-Fornieles J., Bargallo N., Lazaro L., Andres S., Falcon C, Plana M.T., Junque C. Adolescent anorexia nervosa: Cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy. // J. Psychiatr. Res., 2007, 41: 11, 952-958.
102.Chakos M.H., Lieberman J.A., Bilder R.M., Borenstein M., Lerner G., Bogerts В., Wu H., Kinon В., Ashtari M. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs //Am. J. Psychiatry, 1994, 151: 1430-1436.
103.Chakraborty G., Mekala P., Yahya D., Wu G., Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. // J. Neurochemistry, 2001, 78: 736-745.
104.Chambers J.S., Perrone-Bizzozero N.I. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. //Neurochemical Research, 2004, 29: 2293-2302.
105.Chana G., Landau S., Beasley C, Everal LP., Cotter D. Twodimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density // 2003,
53:12: 1086-1098.
188
106.Chang A., Nishiyama A., Peterson J., Prineas J., Trapp B.D. NG2positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. // J. Neurosci., 2000, 20: 17, 6404-6412.
107.Chang L., Friedman J., Ernst Т., Zhong K., Tsopelas N.D., Davis K. Brain Metabolite Abnomialities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction // Biol Psychiatry, 2007, 62: 12, 1396-404.
108.Cheng J.D.and de Vellis J. Oligodendrocytes as glucocorticoids target cells: functional analysis of the glycerol phosphate dehydrogenase gene. // J. Neurosci. Res., 2000, 59: 3, 436-445.
109.Choi B.H.and Lapham L.W. Radial glia in the human fetal cerebrum: A combined Golgi, immunofluorescent and electron microscopic study. // Brain Res., 1978, 148: 295-311.
110.Christensen E., Moller J.E., Faurbye A. Neuropathological investigation of 28 brains from patients with dyskinesia. // Acta Psychiatr. Scand., 1970,46: 14-23.
111.Christensen J., Holcomb J., Garver D.L. State-related changes in cerebral white matter may underlie psychosis exacerbation. // Psychiatry Res., 2004, 130: 1,71-78.
112.Chua SE, Cheung Ch, Cheung V, Tsang JTK, Cheung EYH, Wong JCH, Cheung JPY, Yip L, Tai K, Suckling J, McAlonan GM. Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr. Res., 2006, 89: 12-21.
113.Cid C, Garcia-Villanueva M., Salinas M., Alcazar A. Detection of anti-heat shock protein 90 beta (Hsp90beta) antibodies in cerebrospinal fluid. //J. Immunol. Methods, 2007, 318: 153-157.
114.Clark D., Dedova I., Cordwell S., Matsumoto I. A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. // Mol. Psychiatry, 2006, 11: 459-470.
189
115. Clase A.C., Dimcheff D.E., Favara C, Dorward D., McAtee F.J., Parrie L.E., Ron D., Portis J.L. Oligodendrocytes are a major target of the toxicity of spongiogenic murine retroviruses. // Am. J. Pathol., 2006, 169: 3, 1026-1038.
116.Corson P.W., Nopoulos P., Miller D.D., Arndt S., Andreasen N.C. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. // Am. J. Psychiatry, 1999,156:1200-1204.
117.Cotman C.W. and Berchtold N.C. Exercise: A behavioral intervention to enhance brain health and plasticity. // Trends Neurosci., 2002,25:295-301.
118.Cotter D.R., Pariante СМ., Everall LP. Glial cell abnormalities in major psychiatric disorders: The evidence and implications. // Brain Res. Bull, 2001, 55: 585-595.
119.Cotter D.R., Mackay D., Landau S., Kervin R. Everall I. Reduced glial cell density and neuronal volume in major depression in the anterior cingulated cortex. //Arch. Gen. Psychiatry, 2001, 58: 545-553.
120.Cotter D., Landau S., Beasley C, Stevenson R., Chana G., MacMillan L., Everal I. The density and spatial distribution of GABAergic neurons, labeled using calcium binding proteins, in the anterior cingulate
•cortex in major depressive disorder, bipolar disorder, and schizophrenia. // Biol. Psychiatry, 2002, 51: 377-386.
121.Cotter D., Mackay D., Chana G., Beasley C, Landau S., Everall I. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. // Cerebral Cortex, 2002, 12: 386-394.
122.Cotter D.R., Hudson L., Landau S. Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. // Bipolar Disord., 2005, 7: 4, 358-369.
190
123.Cotter D.R., Pariante CM. Stress and the progression of the developmental hypothesis of schizophrenia. // Br. J. Psychiatry, 2002, 181: 363-365.
124.Cotter D.R., Mackay D., Beasley C.L., Everall I. Landau S. The density, size and spatial pattern distribution of neurons and glia in area 9 prefrontal cortex in schizophrenia, bipolar disorder and major depression. // Schizophr. Res., 2002, 53: 107-108.
125.Crow TJ. Positive and negative schizophrenic symptoms and the role of dopamine: Discussion 2. //Br. J. Psychiatry, 1980, 137: 383-386.
126.Cunlia A.B., Frey B.N., Andreazza A.C., Goi J.D., Rosa A.R., Goncalves C.A., Santin A., Kapczinski F. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. //Neurosci Lett., 2006, 398: 3, 215-219.
127.D'Amelio F., Eng L.F., Gibbs M.A. Glutamine synthetase immunoreactivity is present in oligodendroglia of various regions of the central nervous system. // Glia, 1990, 3: 335-341.
128.Dai X., Lercher L.D., Clinton P.M., Du Y., Livingston D.L., Vieira C, Yang L., Shen M.M., Dreyfus C.F. The trophic role of oligodendrocytes in the basal forebrain. // J. Neurosci., 2003, 23: 5846-5853.
129.Damadzic R., Bigelow L.B., Krimer L.S., Goldenson D.A., Saunders R.C., Kleinman J.E., Herman M.M. A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis. // Brain Research Bulletin, 2001, 55: 611-618.
130.Davis J.M. Dose equivalence of the antipsychotic drugs. // J. Psychiatry Res., 1974, 11: 65-69.
131.Davis S., Thomas A., Perry R., Oakley A., Kalaria R.N., O'Brien J.T. Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study. // J. Neurol. Neurosurg. Psychiatry, 2002, 73: 556-560.